Logo image of CARM.PA

CARMILA (CARM.PA) Stock Fundamental Analysis

EPA:CARM - Euronext Paris - Matif - FR0010828137 - REIT - Currency: EUR

16.96  +0.16 (+0.95%)

Fundamental Rating

4

CARM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. CARM has an average financial health and profitability rating. While showing a medium growth rate, CARM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CARM was profitable.
In the past year CARM had a positive cash flow from operations.
CARM had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CARM had a positive operating cash flow.
CARM.PA Yearly Net Income VS EBIT VS OCF VS FCFCARM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

With a Return On Assets value of 0.78%, CARM perfoms like the industry average, outperforming 47.50% of the companies in the same industry.
CARM has a Return On Equity (1.63%) which is in line with its industry peers.
With a Return On Invested Capital value of 3.06%, CARM is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
CARM had an Average Return On Invested Capital over the past 3 years of 2.84%. This is in line with the industry average of 3.65%.
The last Return On Invested Capital (3.06%) for CARM is above the 3 year average (2.84%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.78%
ROE 1.63%
ROIC 3.06%
ROA(3y)2.14%
ROA(5y)1%
ROE(3y)4.01%
ROE(5y)1.8%
ROIC(3y)2.84%
ROIC(5y)2.75%
CARM.PA Yearly ROA, ROE, ROICCARM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

CARM has a Profit Margin (11.25%) which is comparable to the rest of the industry.
CARM's Profit Margin has declined in the last couple of years.
CARM has a Operating Margin of 60.95%. This is in the lower half of the industry: CARM underperforms 70.00% of its industry peers.
In the last couple of years the Operating Margin of CARM has remained more or less at the same level.
With a Gross Margin value of 73.80%, CARM perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of CARM has remained more or less at the same level.
Industry RankSector Rank
OM 60.95%
PM (TTM) 11.25%
GM 73.8%
OM growth 3Y7.68%
OM growth 5Y-0.02%
PM growth 3YN/A
PM growth 5Y-56.68%
GM growth 3Y5.52%
GM growth 5Y-0.39%
CARM.PA Yearly Profit, Operating, Gross MarginsCARM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100 150 200

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CARM is destroying value.
Compared to 1 year ago, CARM has less shares outstanding
The number of shares outstanding for CARM has been increased compared to 5 years ago.
CARM has a worse debt/assets ratio than last year.
CARM.PA Yearly Shares OutstandingCARM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
CARM.PA Yearly Total Debt VS Total AssetsCARM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that CARM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CARM (0.84) is worse than 60.00% of its industry peers.
The Debt to FCF ratio of CARM is 11.63, which is on the high side as it means it would take CARM, 11.63 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 11.63, CARM is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
CARM has a Debt/Equity ratio of 0.77. This is a neutral value indicating CARM is somewhat dependend on debt financing.
CARM has a Debt to Equity ratio of 0.77. This is comparable to the rest of the industry: CARM outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 11.63
Altman-Z 0.84
ROIC/WACC0.68
WACC4.52%
CARM.PA Yearly LT Debt VS Equity VS FCFCARM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

CARM has a Current Ratio of 1.28. This is a normal value and indicates that CARM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.28, CARM is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
CARM has a Quick Ratio of 1.28. This is a normal value and indicates that CARM is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CARM (1.28) is better than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
CARM.PA Yearly Current Assets VS Current LiabilitesCARM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

CARM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -45.60%.
Measured over the past years, CARM shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -56.15% on average per year.
Looking at the last year, CARM shows a small growth in Revenue. The Revenue has grown by 2.25% in the last year.
The Revenue has been growing slightly by 2.17% on average over the past years.
EPS 1Y (TTM)-45.6%
EPS 3YN/A
EPS 5Y-56.15%
EPS Q2Q%148.17%
Revenue 1Y (TTM)2.25%
Revenue growth 3Y2.48%
Revenue growth 5Y2.17%
Sales Q2Q%1.52%

3.2 Future

Based on estimates for the next years, CARM will show a small growth in Earnings Per Share. The EPS will grow by 5.75% on average per year.
Based on estimates for the next years, CARM will show a small growth in Revenue. The Revenue will grow by 5.13% on average per year.
EPS Next Y5.96%
EPS Next 2Y6.23%
EPS Next 3Y5.75%
EPS Next 5YN/A
Revenue Next Year6.74%
Revenue Next 2Y8.28%
Revenue Next 3Y5.13%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CARM.PA Yearly Revenue VS EstimatesCARM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
CARM.PA Yearly EPS VS EstimatesCARM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 45.84, CARM can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CARM is valued a bit more expensive than 62.50% of the companies in the same industry.
CARM is valuated expensively when we compare the Price/Earnings ratio to 28.58, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.45, the valuation of CARM can be described as very reasonable.
62.50% of the companies in the same industry are more expensive than CARM, based on the Price/Forward Earnings ratio.
CARM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 95.03.
Industry RankSector Rank
PE 45.84
Fwd PE 9.45
CARM.PA Price Earnings VS Forward Price EarningsCARM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CARM's Enterprise Value to EBITDA ratio is in line with the industry average.
CARM's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CARM is cheaper than 77.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.12
EV/EBITDA 16.42
CARM.PA Per share dataCARM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CARM does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)7.69
PEG (5Y)N/A
EPS Next 2Y6.23%
EPS Next 3Y5.75%

2

5. Dividend

5.1 Amount

CARM has a Yearly Dividend Yield of 1.63%. Purely for dividend investing, there may be better candidates out there.
CARM's Dividend Yield is slightly below the industry average, which is at 7.06.
Compared to the average S&P500 Dividend Yield of 2.28, CARM is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.63%

5.2 History

On average, the dividend of CARM grows each year by 9.32%, which is quite nice.
Dividend Growth(5Y)9.32%
Div Incr Years0
Div Non Decr Years0
CARM.PA Yearly Dividends per shareCARM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

CARM pays out 326.31% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CARM is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP326.31%
EPS Next 2Y6.23%
EPS Next 3Y5.75%
CARM.PA Yearly Income VS Free CF VS DividendCARM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M
CARM.PA Dividend Payout.CARM.PA Dividend Payout, showing the Payout Ratio.CARM.PA Dividend Payout.PayoutRetained Earnings

CARMILA

EPA:CARM (2/5/2025, 5:35:30 PM)

16.96

+0.16 (+0.95%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-17 2024-10-17
Earnings (Next)02-11 2025-02-11/amc
Inst Owners30.84%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap2.40B
Analysts77.33
Price Target19.99 (17.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.63%
Yearly Dividend1.17
Dividend Growth(5Y)9.32%
DP326.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.44%
PT rev (3m)4.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-0.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1%
Revenue NY rev (3m)-1%
Valuation
Industry RankSector Rank
PE 45.84
Fwd PE 9.45
P/S 5.16
P/FCF 9.12
P/OCF 8.9
P/B 0.75
P/tB 0.75
EV/EBITDA 16.42
EPS(TTM)0.37
EY2.18%
EPS(NY)1.79
Fwd EY10.58%
FCF(TTM)1.86
FCFY10.97%
OCF(TTM)1.9
OCFY11.23%
SpS3.29
BVpS22.66
TBVpS22.65
PEG (NY)7.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.78%
ROE 1.63%
ROCE 4.8%
ROIC 3.06%
ROICexc 3.53%
ROICexgc 3.53%
OM 60.95%
PM (TTM) 11.25%
GM 73.8%
FCFM 56.54%
ROA(3y)2.14%
ROA(5y)1%
ROE(3y)4.01%
ROE(5y)1.8%
ROIC(3y)2.84%
ROIC(5y)2.75%
ROICexc(3y)3.11%
ROICexc(5y)2.95%
ROICexgc(3y)3.11%
ROICexgc(5y)2.95%
ROCE(3y)4.45%
ROCE(5y)4.3%
ROICexcg growth 3Y13.68%
ROICexcg growth 5Y5.85%
ROICexc growth 3Y13.7%
ROICexc growth 5Y5.86%
OM growth 3Y7.68%
OM growth 5Y-0.02%
PM growth 3YN/A
PM growth 5Y-56.68%
GM growth 3Y5.52%
GM growth 5Y-0.39%
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 11.63
Debt/EBITDA 8.72
Cap/Depr 4273.15%
Cap/Sales 1.37%
Interest Coverage 2.99
Cash Conversion 94.96%
Profit Quality 502.47%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 0.84
F-Score6
WACC4.52%
ROIC/WACC0.68
Cap/Depr(3y)134.51%
Cap/Depr(5y)92.77%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.03%
Profit Quality(3y)3335.16%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.6%
EPS 3YN/A
EPS 5Y-56.15%
EPS Q2Q%148.17%
EPS Next Y5.96%
EPS Next 2Y6.23%
EPS Next 3Y5.75%
EPS Next 5YN/A
Revenue 1Y (TTM)2.25%
Revenue growth 3Y2.48%
Revenue growth 5Y2.17%
Sales Q2Q%1.52%
Revenue Next Year6.74%
Revenue Next 2Y8.28%
Revenue Next 3Y5.13%
Revenue Next 5YN/A
EBIT growth 1Y-2.57%
EBIT growth 3Y10.34%
EBIT growth 5Y2.15%
EBIT Next Year6.12%
EBIT Next 3Y6.1%
EBIT Next 5Y5.77%
FCF growth 1Y-22.6%
FCF growth 3Y17.39%
FCF growth 5Y2.27%
OCF growth 1Y-24.09%
OCF growth 3Y17.99%
OCF growth 5Y2.66%